BlakeMartinPatersonMD

PubMed

• 32 citations
  Preclinical pharmacology and pharmacokinetics of CERC-301, a GluN2B-selective N-methyl-D-aspartate receptor antagonist.
  Rachel M Garner, Shobha Gopalakrishnan, John A. Mccauley, Rodney A. Bednar, Stanley L. Gaul, Scott D. Mosser, Laszlo Kiss, Joseph J. Lynch, Shil Patel, Christine Fando...> ;Pharmacology Research & Perspectives. 2015 Dec 1
• 14 citations
  Effect of Memantine on Cough Reflex Sensitivity: Translational Studies in Guinea Pigs and Humans
  Peter V. Dicpinigaitis, Brendan Canning, Rachel M Garner, Blake Paterson> ;The Journal of Pharmacology and Experimental Therapeutics. 2015 Mar 1
• 1 citations
  Commentary: larazotide acetate ‐ an exciting new development for coeliac patients? Authors’ reply
  Ciaran P. Kelly, Peter H.R. Green, Joseph A. Murray, Anthony J. DiMarino, Anthony M. Colatrella, Daniel A. Leffler, T. Alexander, Razvan Arsenescu, Francisco León, Joh...> ;Alimentary Pharmacology & Therapeutics. 2013 Feb 1
• 134 citations
  Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo‐controlled study
  Ciaran P. Kelly, Peter H.R. Green, Joseph A. Murray, Anthony J. DiMarino, Anthony M. Colatrella, Daniel A. Leffler, T. Alexander, Razvan Arsenescu, Francisco León, Joh...> ;Alimentary Pharmacology & Therapeutics. 2013 Jan 1
• A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge.
  Leffler DA, Kelly CP, Abdallah HZ, Colatrella AM, Harris LA, Leon F, Arterburn LA, Paterson BM, Lan ZH, Murray JA> ;Am. J. Gastroenterol.. 2012-10-01
• 79 citations
  Larazotide acetate regulates epithelial tight junctions in vitro and in vivo
  Shobha Gopalakrishnan, Malarvizhi Durai, Kelly Kitchens, Amir P. Tamiz, Robert Somerville, Mark Ginski, Blake Paterson, Joseph A. Murray, Elena F. Verdu, Sefik S. Alka...> ;Peptides. 2012 May 1
• 62 citations
  Mechanism of action of ZOT-derived peptide AT-1002, a tight junction regulator and absorption enhancer
  Shobha Gopalakrishnan, Niranjan B. Pandey, Amir P. Tamiz, John Vere, Rosa Carrasco, Robert Somerville, Amit Tripathi, Mark J. Ginski, Blake Paterson, Sefik S. Alkan> ;International Journal of Pharmaceutics. 2009 Jan 5
• The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study.
  Paterson, B. M.,Lammers, K. M.,Arrieta, M. C.,Fasano, A.,Meddings, J. B.> ;Aliment. Pharmacol. Ther.. 2007 Aug 19
• 28 citations
  Expression Levels of Protein Kinase C-α in Non–Small-Cell Lung Cancer
  Michael Lahn, Chen Su, Shuyu Li, Marcio Chedid, Kimberly R. Hanna, Jeremy R. Graff, George E. Sandusky, Doreen Ma, Clet Niyikiza, Karen Sundell, William J. John, Thoma...> ;Clinical Lung Cancer. 2004 Nov 1
• Protein kinase C-alpha in prostate cancer.
  Lahn M, Sundell K, Gleave M, Ladan F, Su C, Li S, Ma D, Paterson BM, Bumol TF> ;BJU Int.. 2004-05-01
• 5 citations
  The role of protein kinase C-α in malignancies of the nervous system and implications for the clinical development of the specific PKC-α inhibitor aprinocarsen (Review)
  Michael Lahn, Karen Sundell, Blake M. Paterson> ;Oncology Reports. 2004 Feb 1
• 72 citations
  Protein Kinase C Alpha Expression in Breast and Ovarian Cancer
  Michael Lahn, Gabriele Köhler, Karen Sundell, Chen Su, Shuyu Li, Blake M. Paterson, Thomas Frank Bumol> ;Oncology. 2004 Jan 1
• The role of protein kinase C-alpha (PKC-alpha) in malignancies of the gastrointestinal tract.
  Lahn M, Paterson BM, Sundell K, Ma D> ;Eur. J. Cancer. 2004-01-01
• Join now to see all